Zogenix, Inc. (ZGNX) Officers To Report Withholding Of Shares
6/2/2014 9:17:23 AM
SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related and central nervous system (CNS) disorders, announced today that certain of its executive officers will submit Form 4 filings pursuant to Section 16 of the Securities Exchange Act of 1934.
Help employers find you! Check out all the jobs and post your resume.
comments powered by